In the CNS melanocortins have proven to be anti-inflammatory and neuroprotective peptides in models of brain ischemia [13, 14] and sepsis [15] and to improve cognitive function, acting through MC4R, in a model of Alzheimer’s disease (AD) [16] or after cytokine treatment [17–19]. Here, MC4R is linked to Alzheimer disease.